NVO gains ground in the GLP-1 battle as Ozempic outshines Trulicity in heart risk reduction and Rybelsus wins EU approval for ...

Bagsværd, Denmark Saturday, September 20, 2025, 11:00 Hrs [IST] ...

AstraZeneca is throwing one last Hail Mary following a string of Big Pharma defeats challenging the legality of the Inflation ...

ProKidney shows strong Phase 2 CKD data, FDA support, and cash runway, with key readouts ahead despite single-asset risks.

Pfizer enters the obesity drug market with its Metsera acquisition, aiming to challenge leaders Eli Lilly and Novo Nordisk.

Under an expanded agreement with its customer argenx SE, a Belgian biopharmaceutical company, FUJIFILM will produce a drug ...

The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision.

Are GLP-1 weight loss drugs the best we can do? Learn why some are pursuing alternatives to appetite suppression.

FOR many, fat jabs have done a world of good – dulling hunger pangs and banishing maddening “food noise”, causing pounds to ...

Lower eGFRs were associated with higher likelihood of developing kidney failure and death among adults with diabetes, ...

DelveInsight's SGLT2 Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

(CNN) — This week, officials confirmed 21 cases of Legionnaires' disease and one death in Marshall County. This comes after an outbreak this summer in New York that led to seven deaths and 114 ...